High incidence and reversible bradycardia events following alectinib initiation.
Dongqi YuanFuyi ZhuRan ZuoYu WangGengwei HuoJinfang CuiPing YuePeng ChenPublished in: Thoracic cancer (2022)
Alectinib-induced bradycardia had a high incidence, appeared relatively early, and was reversible by dose reduction or withdrawal.